← Back to Search

Procedure

tDCS for Motor Skill Improvement

N/A
Recruiting
Led By Sydney Schaefer, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days
Awards & highlights

Study Summary

This trial tests if setting expectations can help make a medical treatment (tDCS) more effective in improving motor skills.

Who is the study for?
This trial is for right-handed adults who have never had seizures, head injuries with loss of consciousness requiring further investigation, or any implanted devices like pacemakers. It's not for those who are pregnant, ambidextrous, suffer from migraines or psychological/neurological conditions, have metal in their head (except dental), scalp skin conditions, unhealed head wounds, adverse reactions to brain stimulation techniques or currently taking medication/drugs.Check my eligibility
What is being tested?
The study is examining whether setting up positive expectations can boost the effectiveness of transcranial Direct Current Stimulation (tDCS) in improving motor learning skills.See study design
What are the potential side effects?
While tDCS is generally considered safe, potential side effects may include mild tingling on the scalp, slight itching under the electrode pads during stimulation, a brief headache or fatigue following treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three days
This trial's timeline: 3 weeks for screening, Varies for treatment, and three days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance on motor task one week after final training session
Secondary outcome measures
Average dwell time
Average peak reach velocity
Change in motor performance over the course of training
+3 more

Side effects data

From 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468
2%
Car accident
2%
skin irritation
100%
80%
60%
40%
20%
0%
Study treatment Arm
tDCS (Active)
tDCS (Sham)

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: tDCS3Experimental Treatment1 Intervention
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Group II: tDCS2Experimental Treatment1 Intervention
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
Group III: tDCS1Experimental Treatment1 Intervention
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
Group IV: ControlActive Control1 Intervention
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation
2014
Completed Phase 3
~1100

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
109,372 Total Patients Enrolled
Sydney Schaefer, PhDPrincipal InvestigatorArizona State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are participating in this research initiative?

"Affirmative. According to the information on clinicaltrials.gov, this study is actively seeking candidates and posted for the first time on October 1st 2023 with a most recent update from October 19th of that same year. The trial requires 142 participants at one site in particular."

Answered by AI

Are there any unoccupied slots in this clinical research initiative?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial has been initiated since October 1st, 2023 and is up-to-date as of October 19th, 2023. They are presently trying to recruit 142 people from a single physical site for participation in the research study."

Answered by AI
~95 spots leftby Jun 2025